Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05465408 · ClinicalTrials.gov registry record · NA
Culturally Aware AET Non-Initiation Intervention
A NA study of Breast Cancer and Survivorship, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 11
- Study locations
NCT05465408 is a NA study of Breast Cancer and Survivorship that has completed, run by Massachusetts General Hospital. The registered enrollment target is 35 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 11 study locations across 2 states.
The verdict
NCT05465408, a NA study of Breast Cancer and Survivorship, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 11
- Study locations
Study Summary
The purpose of this study is to examine the feasibility and acceptability of a brief, nurse-led intervention to support breast cancer survivors who have delayed initiation of hormonal therapy or who have concerns about starting hormonal therapy.
Conditions Studied
Interventions
- BEHAVIORAL Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation Intervention
Study Locations (11)
Massachusetts
- Massachusetts General Hospital Cancer Center - Boston
- Dana-Farber Cancer Institute - Boston
- Dana-Farber Cancer Institute at St Elizabeth's Medical Center - Brighton
- Emerson Hospital/MGH Cancer Center - Concord
- Mass General at North Shore Cancer Center - Danvers
- Dana-Farber Brigham Cancer Center - Foxborough - Foxborough
- Dana-Farber Cancer Institute - Merrimack Valley - Methuen
- Dana-Farber Brigham Cancer Center at Milford Regional Medical Center - Milford
- Mass General at Newton Wellesley Hospital - Newton
- Dana-Farber Brigham Cancer Center with South Shore Hospital - Weymouth
New Hampshire
- Dana-Farber/New Hampshire Onoclogy-Hematology - Londonderry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2022-07-21 |
| Est. Completion | 2024-11-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05465408
The ClinicalTrials.gov registry entry for NCT05465408 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation Intervention is the first listed.
NCT05465408 reports 11 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, New Hampshire.
Frequently Asked Questions
What is clinical trial NCT05465408 about?
NCT05465408 is a clinical study titled "Culturally Aware AET Non-Initiation Intervention". The purpose of this study is to examine the feasibility and acceptability of a brief, nurse-led intervention to support breast cancer survivors who have delayed initiation of hormonal therapy or who have concerns about starting hormonal therapy.
What is the current status of trial NCT05465408?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2022-07-21. Estimated completion is 2024-11-20.
What conditions does trial NCT05465408 study?
This clinical trial studies the following conditions: Breast Cancer, Survivorship, Treatment Adherence, Treatment Refusal, Treatment Compliance.
What interventions are being tested in trial NCT05465408?
The interventions under investigation include: Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05465408?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05465408 being conducted?
This trial has 11 study locations across Massachusetts, New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.